EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

O-GlcNAc modification differentially regulates microtubule binding and pathological conformations of tau isoforms in vitro

Mohammed M Alhadidy, Paul M Stemmer, Nicholas M Kanaan

Journal of Biological Chemistry · 2025

DOI: 10.1016/j.jbc.2025.108263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Mohammed M Alhadidy und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Neuroscience, College of Human Medicine, Michigan State University, Grand Rapids, Michigan, United States; Neuroscience P…. Hauptthemen laut MEDLINE: tau Proteins, Microtubules, Acetylglucosamine, Protein Processing, Post-Translational. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tau proteins undergo several posttranslational modifications in physiological and disease conditions. In Alzheimer's disease, O-GlcNAcylation modification of serine/threonine (S/T) residues in tau is reduced. In mouse models of tauopathy, O-GlcNAcase inhibitors lead to increased O-GlcNAcylation and decreased filamentous aggregates of tau. However, various nonfilamentous tau conformations, linked to toxicity and neurodegeneration in tauopathies, involve processes like oligomerization, misfolding, and greater exposure of the phosphatase-activating domain in the amino terminus of tau. Additionally, it is becoming clearer that posttranslational modifications may differently regulate tau pathobiology in an isoform-dependent manner. Therefore, it is crucial to investigate the effects of O-GlcNAcylation on nonfilamentous conformations of both the four-repeat (4R, e.g., hT40) and three-repeat (3R, e.g., hT39) tau isoforms. In this study, we assessed how O-GlcNAcylation impacts pathological tau conformations of the longest 4R and 3R tau isoforms (hT40 and hT39, respectively) using recombinant proteins. Mass spectrometry showed that tau is modified with O-GlcNAc at multiple S/T residues, primarily in the proline-rich domain and the C-terminal region. O-GlcNAcylation of hT40 and hT39 does not affect microtubule polymerization but has opposite effects on hT40 (increases) and hT39 (decreases) binding to preformed microtubules. Although O-GlcNAcylation interferes with forming filamentous hT40 aggregates, it does not alter the formation of pathological nonfilamentous tau conformations. On the other hand, O-GlcNAcylation increases the formation of pathological nonfilamentous hT39 conformations. These findings suggest that O-GlcNAcylation differentially modulates microtubule binding and the adoption of pathological tau conformations in the longest 4R and 3R tau isoforms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsMicrotubulesAcetylglucosamineProtein Processing, Post-TranslationalProtein IsoformsHumansAnimalsGlycosylationMiceProtein ConformationProtein BindingTauopathiesAlzheimer DiseaseAcylation

Stichwörter der Autor:innen

Alzheimer’s diseaseO-glycosylationaggregationfilamentsmicrotubulesoligomersphosphatase-activating domainposttranslational modificationprotein conformationprotein misfoldingrecombinant proteintautauopathy

Substanzen

tau ProteinsProtein IsoformsAcetylglucosamineMAPT protein, human

Autor:innen und Institutionen

  • Department of Translational Neuroscience, College of Human Medicine, Michigan State University, Grand Rapids, Michigan, United States; Neuroscience Program, Michigan State University, East Lansing, Michigan, United Stat…
  • Institute of Environmental Health Sciences, Wayne State University, Detroit, Michigan, United States; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Wayne State University, Detroit, Mich…

Förderung

  • NIEHS NIH HHS
  • NIH HHS
  • NINDS NIH HHS
  • NCI NIH HHS
  • NIA NIH HHS
  • National Institute on Aging
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Alhadidy, M. M., Stemmer, P. M., & Kanaan, N. M. (2025). O-GlcNAc modification differentially regulates microtubule binding and pathological conformations of tau isoforms in vitro. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.108263

Vancouver

Alhadidy MM, Stemmer PM, Kanaan NM. O-GlcNAc modification differentially regulates microtubule binding and pathological conformations of tau isoforms in vitro. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.108263

BibTeX
@article{Alhadidy2025,
  author = {Alhadidy, Mohammed M and Stemmer, Paul M and Kanaan, Nicholas M},
  title = {O-GlcNAc modification differentially regulates microtubule binding and pathological conformations of tau isoforms in vitro},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  doi = {10.1016/j.jbc.2025.108263}
}
Kostenlos starten →